user

Life course socioeconomic conditions, multimorbidity and polypharmacy in older adults

被引：0
|
作者：
Jungo, K. T. [1 ]
Cheval, B. [2 ]
Sieber, S. [3 ,4 ]
van der Linden, B. W. A. [5 ,6 ]
Ihle, A. [3 ,5 ,8 ]
Carmeli, C. [7 ]
Chiolero, A. [1 ,7 ,9 ]
Streit, S. [1 ]
Cullati, S. [7 ,10 ]
机构：
[1] Univ Bern, Inst Primary Hlth Care, Bern, Switzerland
[2] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland
[3] Univ Geneva, Swiss NCCR, Geneva, Switzerland
[4] Univ Geneva, Inst Demog & Socioecon, Geneva, Switzerland
[5] Univ Geneva, CIGEV, Geneva, Switzerland
[6] Univ Penn, Populat Aging Res Ctr, Philadelphia, PA 19104 USA
[7] Univ Fribourg, Populat Hlth Lab, Fribourg, Switzerland
[8] Univ Geneva, Dept Psychol, Geneva, Switzerland
[9] McGill Univ, Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[10] Univ Geneva, Dept Readaptat & Geriatr, Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF PUBLIC HEALTH | 2020年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Optimizing Prescribing in Older Adults with Multimorbidity and Polypharmacy in Primary Care: A Cluster Randomized Clinical Trial
    Jungo, K. T.
    Ansorg, A.
    Floriani, C.
    Rozsnyai, Z.
    Schwab, N.
    Meier, R.
    Valeri, F.
    Stalder, O.
    Limacher, A.
    Schneider, C.
    Bagattini, M.
    Trelle, S.
    Spruit, M.
    Schwenkglenks, M.
    Rodondi, N.
    Streit, S.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S122 - S122
  • [32] Life-course socioeconomic status and its impact on functional health of Portuguese older adults
    Henriques, Ana
    Ruano, L.
    Fraga, S.
    Soares, S.
    Barros, H.
    Talih, M.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2023, 33
  • [33] Economic Evaluations of Interventions to Optimize Medication Use in Older Adults with Polypharmacy and Multimorbidity: A Systematic Review
    Laberge, Maude
    Sirois, Caroline
    Lunghi, Carlotta
    Gaudreault, Myriam
    Nakamura, Yumiko
    Bolduc, Carolann
    Laroche, Marie-Laure
    [J]. CLINICAL INTERVENTIONS IN AGING, 2021, 16 : 767 - 779
  • [34] COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy
    Ailabouni, Nagham J.
    Hilmer, Sarah N.
    Kalisch, Lisa
    Braund, Rhiannon
    Reeve, Emily
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (06): : 1068 - 1073
  • [35] An overview of multimorbidity and polypharmacy in older people living with HIV
    Yang, Chen
    Teh, Yii Ean
    Chua, Nathalie Grace Sy
    Lee, Kiat Loon Simon
    Ng, Rachel Qiao Ming
    [J]. GERIATRICS & GERONTOLOGY INTERNATIONAL, 2024, 24 : 49 - 59
  • [36] Life Course Socioeconomic Conditions and Metabolic Syndrome in Adults: The Atherosclerosis Risk in Communities (ARIC) Study
    Chichlowska, Kristal L.
    Rose, Kathryn M.
    Diez-Roux, Ana V.
    Golden, Sherita H.
    Mcneill, Annie M.
    Heiss, Gerardo
    [J]. ANNALS OF EPIDEMIOLOGY, 2009, 19 (12) : 875 - 883
  • [37] PREVALENCE OF POLYPHARMACY IN OLDER ADULTS
    Hofmann, G.
    Hach, I.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 6 - 6
  • [38] The Effects of Polypharmacy in Older Adults
    Hilmer, S. N.
    Gnjidic, D.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (01) : 86 - 88
  • [39] About polypharmacy in older adults
    Jacob, Javier
    Pena, Barbara
    Herrero-Puente, Pablo
    [J]. MEDICINA CLINICA, 2021, 156 (06): : 307 - 307
  • [40] DEPRESCRIBING IN OLDER ADULTS WITH POLYPHARMACY
    Zermansky, Arnold
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
12345